The TACR3 gene hypogonadotropic hypogonadism type 11 with or without anosmia genetic test is a specialized diagnostic procedure available at DNA Labs UAE. This test, priced at 4400 AED, is designed to identify mutations in the TACR3 gene, which are linked to a specific form of hypogonadotropic hypogonadism (HH). Type 11 HH is a condition characterized by a reduced function of the gonads due to an inadequate secretion of gonadotropins from the pituitary gland, which can manifest with or without anosmia (the loss of the sense of smell).
The TACR3 gene plays a critical role in the development and function of the reproductive system by regulating the release of gonadotropin-releasing hormone (GnRH). Mutations in this gene can disrupt normal sexual development and lead to delayed or absent puberty, infertility, and other reproductive system abnormalities.
The genetic test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the TACR3 gene. This test is crucial for individuals who exhibit symptoms of hypogonadotropic hypogonadism, as it can confirm the diagnosis and help in tailoring appropriate treatment and management strategies. Additionally, identifying the genetic cause of the condition can provide valuable information for family planning and genetic counseling.
DNA Labs UAE offers this comprehensive genetic testing service with state-of-the-art technology and expertise, ensuring accurate and reliable results for patients seeking answers to their reproductive health concerns.
The "GNRH1 Gene Hypogonadotropic Hypogonadism Type 12 with or Without Anosmia Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GNRH1 gene. These mutations are associated with Hypogonadotropic Hypogonadism Type 12, a condition characterized by delayed or absent puberty and reduced function of the gonads. The test also explores the presence or absence of anosmia, the loss of the sense of smell, which can sometimes accompany the condition. By analyzing the patient's DNA, this test provides crucial information for the diagnosis, management, and treatment planning of individuals affected by this genetic disorder. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results.
The HS6ST1 gene hypogonadotropic hypogonadism type 15 with or without anosmia genetic test is a specialized diagnostic tool used to identify mutations in the HS6ST1 gene, which are linked to a specific form of hypogonadotropic hypogonadism (HH). Hypogonadotropic hypogonadism is a condition characterized by insufficient production of gonadotropins, hormones that are essential for sexual development and reproduction. Type 15 of this condition may also be associated with anosmia, the loss of the sense of smell, depending on the genetic mutation present.
This test is crucial for individuals exhibiting symptoms of HH type 15, as it allows for a precise diagnosis, enabling targeted treatment and management of the condition. Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities, the test involves analyzing the patient's DNA to detect abnormalities in the HS6ST1 gene.
The cost of the HS6ST1 gene hypogonadotropic hypogonadism type 15 with or without anosmia genetic test is 4400 AED. This investment covers the sophisticated processes involved in isolating, amplifying, and sequencing the patient's DNA to identify any mutations responsible for the condition. Given the specialized nature of this test and its significance in providing critical insights for managing HH type 15, the cost reflects the value of the detailed genetic information obtained.
By opting for this test at DNA Labs UAE, patients and healthcare providers can make informed decisions about treatment strategies, potentially improving quality of life and mitigating the symptoms associated with hypogonadotropic hypogonadism type 15.
The PROKR2 gene hypogonadotropic hypogonadism type 3 with or without anosmia genetic test is a specialized diagnostic procedure offered by DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the PROKR2 gene, which are associated with a rare condition known as hypogonadotropic hypogonadism type 3. This condition affects the body's ability to produce hormones responsible for sexual development and can lead to delayed or absent puberty. Some individuals may also experience anosmia, the loss of the sense of smell, as a related symptom. The test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for genetic abnormalities in the PROKR2 gene. Results from this test can provide crucial information for diagnosis, allowing for personalized treatment plans and management strategies for affected individuals and their families.
The GNRHR Gene Hypogonadotropic Hypogonadism Type 7 with or Without Anosmia Genetic Test is a specialized diagnostic assessment offered at DNA Labs UAE. This test is designed to identify mutations in the GNRHR gene, which are associated with Hypogonadotropic Hypogonadism Type 7, a condition characterized by a lack of sexual development and, in some cases, the absence of the sense of smell (anosmia). The GNRHR gene plays a crucial role in the regulation of hormone secretion necessary for sexual development and reproductive function. The presence of mutations in this gene can lead to the disrupted signaling pathway of gonadotropin-releasing hormone (GnRH), resulting in the condition.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for genetic abnormalities in the GNRHR gene. It is a critical tool for individuals experiencing symptoms of hypogonadotropic hypogonadism, providing them with essential information for diagnosis, treatment planning, and understanding the risk of passing the condition to their offspring.
The AMT Gene Glycine Encephalopathy Genetic Test is a specialized diagnostic procedure designed to identify mutations in the AMT gene, which are linked to Glycine Encephalopathy, also known as Nonketotic Hyperglycinemia (NKH). This rare genetic disorder disrupts the normal metabolism of the amino acid glycine, leading to an accumulation in the body that can cause severe neurological symptoms, including intellectual disability, seizures, and hypotonia. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
Performed at DNA Labs UAE, this test involves analyzing the patient's DNA to detect mutations in the AMT gene that are responsible for the condition. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. By identifying the specific genetic alterations causing Glycine Encephalopathy, this test enables targeted interventions and supports families in understanding their genetic risk for future pregnancies.
The GLDC Gene Glycine Encephalopathy Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the GLDC gene, which are linked to Glycine Encephalopathy (GE). Also known as non-ketotic hyperglycinemia, GE is a rare genetic disorder that affects the body's ability to process the amino acid glycine, leading to an accumulation that can cause severe neurological issues, including developmental delay, seizures, and hypotonia. This genetic test is crucial for early detection and management of the condition, offering insights that can guide treatment and support strategies. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of mutations in the GLDC gene. By opting for this test at DNA Labs UAE, patients and their families can access critical information that can significantly impact the management and understanding of Glycine Encephalopathy, facilitating a more informed approach to care and intervention.
Glycine N-methyltransferase (GNMT) deficiency is a rare genetic disorder that can lead to various health issues, including liver disease, increased risk of liver cancer, and potential neurological complications. The GNMT gene plays a crucial role in the metabolism of amino acids, specifically in the methylation process of glycine, which is vital for detoxification and the synthesis of DNA and proteins.
To diagnose this condition, a genetic test targeting the GNMT gene can be conducted. This test is crucial for individuals with a family history of GNMT deficiency or those exhibiting symptoms related to the disorder. Early diagnosis through genetic testing allows for timely intervention and management strategies to mitigate health risks associated with the condition.
In the UAE, DNA Labs UAE offers the GNMT Gene Glycine N-Methyltransferase Deficiency Genetic Test. The test is meticulously designed to identify mutations in the GNMT gene, providing a comprehensive analysis for accurate diagnosis. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to conduct this specialized genetic analysis.
By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and lifestyle. The test is conducted under strict confidentiality, ensuring privacy and security for all clients.
The KEAP1 Gene Goitre Multinodular Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the KEAP1 gene, which have been associated with the development of multinodular goitre. Multinodular goitre is a condition characterized by the enlargement of the thyroid gland, leading to the formation of multiple nodules. This test is crucial for individuals who have a family history of thyroid issues or have been identified with symptoms related to thyroid gland abnormalities. By analyzing the genetic makeup of an individual, the test aims to provide insights into the genetic predisposition towards developing multinodular goitre, thereby aiding in early detection, management, and personalized treatment planning. The cost of the KEAP1 Gene Goitre Multinodular Genetic Test at DNA Labs UAE is 4400 AED, reflecting the specialized nature of the test and the comprehensive analysis it entails.
The GH1 gene growth hormone deficiency genetic test is a specialized diagnostic tool used to identify mutations in the GH1 gene, which can lead to growth hormone deficiency (GHD) in individuals. GHD is a condition characterized by inadequate production of growth hormone, leading to various health issues such as delayed growth in children, decreased muscle mass, and impaired metabolism. The test involves analyzing the DNA to pinpoint any genetic anomalies in the GH1 gene that may be causing the deficiency.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis for those suspected of having GHD due to genetic factors. By identifying the specific genetic mutation, healthcare providers can better understand the condition and tailor treatment plans to address the deficiency effectively.
The cost of the GH1 gene growth hormone deficiency genetic test at DNA Labs UAE is 4400 AED. This price reflects the advanced technology and expertise required to accurately identify mutations in the GH1 gene and provide individuals with crucial information regarding their health and treatment options.
